A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML Journal Article


Authors: Chen, B. R.; Deshpande, A.; Barbosa, K.; Kleppe, M.; Lei, X.; Yeddula, N.; Sánchez Vela, P.; Campos, A. R.; Wechsler-Reya, R. J.; Bagchi, A.; Meshinchi, S.; Eaves, C.; Jeremias, I.; Haferlach, T.; Frank, D. A.; Ronai, Z.; Chanda, S.; Armstrong, S. A.; Adams, P. D.; Levine, R. L.; Deshpande, A. J.
Article Title: A JAK/STAT-mediated inflammatory signaling cascade drives oncogenesis in AF10-rearranged AML
Abstract: Leukemias bearing fusions of the AF10/MLLT10 gene are associated with poor prognosis, and therapies targeting these fusion proteins (FPs) are lacking. To understand mechanisms underlying AF10 fusion-mediated leukemogenesis, we generated inducible mouse models of acute myeloid leukemia (AML) driven by the most common AF10 FPs, PICALM/CALM-AF10 and KMT2A/MLL-AF10, and performed comprehensive characterization of the disease using transcriptomic, epigenomic, proteomic, and functional genomic approaches. Our studies provide a detailed map of gene networks and protein interactors associated with key AF10 fusions involved in leukemia. Specifically, we report that AF10 fusions activate a cascade of JAK/STAT-mediated inflammatory signaling through direct recruitment of JAK1 kinase. Inhibition of the JAK/STAT signaling by genetic Jak1 deletion or through pharmacological JAK/STAT inhibition elicited potent antioncogenic effects in mouse and human models of AF10 fusion AML. Collectively, our study identifies JAK1 as a tractable therapeutic target in AF10-rearranged leukemias. © 2021 by The American Society of Hematology.
Journal Title: Blood
Volume: 137
Issue: 24
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2021-06-17
Start Page: 3403
End Page: 3415
Language: English
DOI: 10.1182/blood.2020009023
PUBMED: 33690798
PROVIDER: scopus
PMCID: PMC8212510
DOI/URL:
Notes: Article -- Export Date: 1 July 2021 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine
  2. Maria Kleppe
    41 Kleppe